Your session is about to expire
← Back to Search
Genetics ADvISER Decision Aid for Cancer
N/A
Waitlist Available
Led By Yvonne Bombard, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Speak and read English.
18 years old or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at immediately after baseline/ post intervention, 2 months and 4 months.
Awards & highlights
Study Summary
This trial will help researchers understand if a digital decision support tool can help patients make choices about which results from genomic sequencing they wish to receive.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed at immediately after baseline/ post intervention, 2 months and 4 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at immediately after baseline/ post intervention, 2 months and 4 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Decisional Conflict Scale (DCS)
Secondary outcome measures
Acceptability
Hospital Anxiety and Depression Scale (HADS)
Knowledge
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Genetics ADviSER Decision Aid Plus Standard Genetic CounsellingExperimental Treatment1 Intervention
Participants in the intervention arm will use the Genetics ADviSER to learn about genomic sequencing and to select which results they would like to receive from genomics sequencing results. After using the Genetics ADviSER decision aid they will speak with genetic counselor to discuss their choices and to finalized their selection.
Group II: Standard Genetic Counselling OnlyActive Control1 Intervention
Participants will speak with a genetic counsellor over the phone to learn about genomic sequencing and select which incidental findings they would like to receive from genomic sequencing.
Find a Location
Who is running the clinical trial?
Unity Health TorontoLead Sponsor
536 Previous Clinical Trials
447,396 Total Patients Enrolled
Yvonne Bombard, PhDPrincipal InvestigatorSt. Michael's Hospital and University of Toronto
2 Previous Clinical Trials
422 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Standard Genetic Counselling Only
- Group 2: Genetics ADviSER Decision Aid Plus Standard Genetic Counselling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are investigators currently looking for more participants for this research?
"This study is actively recruiting patients, as reported on clinicaltrials.gov. The study was originally posted on 6/22/2021 and was last updated on 4/12/2022."
Answered by AI
How many test subjects are participating in this experiment?
"That is correct. The information available on clinicaltrials.gov affirms that this study, which was originally posted on 6/22/2021, is actively seeking patients for participation. This trial will have 130 patients at 3 different locations."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger